Daniel Klamer, PhD, MBA

Daniel Klamer, PhD, MBA is the Vice President of Business Development & Scientific Strategy at Anavex Life Sciences. With a background in pharmacology and neuroscience, Daniel has played key roles in various companies, from co-founding startups to leading research projects. Known for their expertise in drug development and commercialization, Daniel has made significant contributions to the field of neurodegenerative and neurodevelopmental diseases.